These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32168331)

  • 1. In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits.
    Guo X; Luo S; Amidani D; Rivetti C; Pieraccini G; Pioselli B; Catinella S; Murgia X; Salomone F; Xu Y; Dong Y; Sun B
    PLoS One; 2020; 15(3):e0230229. PubMed ID: 32168331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo comparison between poractant alfa and the new generation synthetic surfactant CHF5633.
    Ricci F; Murgia X; Razzetti R; Pelizzi N; Salomone F
    Pediatr Res; 2017 Feb; 81(2):369-375. PubMed ID: 27973472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of poractant alfa and lyophilized lucinactant in a preterm lamb model of acute respiratory distress.
    Mazela J; Merritt A; Terry MH; Gregory TJ; Blood AB
    Pediatr Res; 2012 Jul; 72(1):32-7. PubMed ID: 22465908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
    Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S
    J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.
    Bianco F; Ricci F; Catozzi C; Murgia X; Schlun M; Bucholski A; Hetzer U; Bonelli S; Lombardini M; Pasini E; Nutini M; Pertile M; Minocchieri S; Simonato M; Rosa B; Pieraccini G; Moneti G; Lorenzini L; Catinella S; Villetti G; Civelli M; Pioselli B; Cogo P; Carnielli V; Dani C; Salomone F
    Respir Res; 2019 Jul; 20(1):134. PubMed ID: 31266508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs.
    Seehase M; Collins JJ; Kuypers E; Jellema RK; Ophelders DR; Ospina OL; Perez-Gil J; Bianco F; Garzia R; Razzetti R; Kramer BW
    PLoS One; 2012; 7(10):e47631. PubMed ID: 23091635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: a retrospective cohort study.
    Paul S; Rao S; Kohan R; McMichael J; French N; Zhang G; Simmer K
    J Paediatr Child Health; 2013 Oct; 49(10):839-44. PubMed ID: 23802801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits.
    Zebialowicz Ahlström J; Massaro F; Mikolka P; Feinstein R; Perchiazzi G; Basabe-Burgos O; Curstedt T; Larsson A; Johansson J; Rising A
    Respir Res; 2019 Nov; 20(1):245. PubMed ID: 31694668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial.
    Ramanathan R; Biniwale M; Sekar K; Hanna N; Golombek S; Bhatia J; Naylor M; Fabbri L; Varoli G; Santoro D; Del Buono D; Piccinno A; Dammann CE
    J Pediatr; 2020 Oct; 225():90-96.e1. PubMed ID: 32553868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary distribution of lucinactant and poractant alfa and their peridosing hemodynamic effects in a preterm lamb model of respiratory distress syndrome.
    Terry MH; Merritt TA; Harding B; Schroeder H; Merrill-Henry J; Mazela J; Gregory TJ; Segal R; Power GG; Blood AB
    Pediatr Res; 2010 Sep; 68(3):193-8. PubMed ID: 20531255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of synthetic surfactant (CHF5633) bolus and/or lavage in meconium-induced lung injury in ventilated newborn rabbits.
    Xu Y; Guo X; Chen M; Ricci F; Salomone F; Murgia X; Sun B
    Pediatr Res; 2023 Feb; 93(3):541-550. PubMed ID: 35701606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of synthetic surfactant CHF5633 with SP-B and SP-C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome.
    Mikolka P; Curstedt T; Feinstein R; Larsson A; Grendar M; Rising A; Johansson J
    Physiol Rep; 2021 Jan; 9(1):e14700. PubMed ID: 33403805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
    Dizdar EA; Sari FN; Aydemir C; Oguz SS; Erdeve O; Uras N; Dilmen U
    Am J Perinatol; 2012 Feb; 29(2):95-100. PubMed ID: 22105435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
    Ramanathan R; Rasmussen MR; Gerstmann DR; Finer N; Sekar K;
    Am J Perinatol; 2004 Apr; 21(3):109-19. PubMed ID: 15085492
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ricci F; Salomone F; Kuypers E; Ophelders D; Nikiforou M; Willems M; Krieger T; Murgia X; Hütten M; Kramer BW; Bianco F
    Front Pediatr; 2017; 5():186. PubMed ID: 28913327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis.
    Singh N; Hawley KL; Viswanathan K
    Pediatrics; 2011 Dec; 128(6):e1588-95. PubMed ID: 22123870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome.
    Kadıoğlu Şimşek G; Kanmaz Kutman HG; Canpolat FE; Oğuz ŞS
    Clin Respir J; 2020 Mar; 14(3):285-290. PubMed ID: 31814293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.